Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhangjiang Leading Capital, officially known as Shanghai Zhangjiang Leading Investment Management Co., Ltd., is a specialized venture capital firm and the investment arm of the state-owned Zhangjiang Group. Based in Shanghai's Zhangjiang Hi-Tech Park, the firm is dedicated to fostering the "Pharma Valley" ecosystem by providing early-stage and growth capital to innovative life sciences and biotechnology companies. It manages a variety of healthcare-focused funds, including the Zhangjiang Science City Life Science Fund, which targets breakthroughs in drug discovery, medical devices, and diagnostics. The firm leverages its deep integration with the Zhangjiang Hi-Tech ecosystem to provide strategic support and industrial resources to its portfolio companies. Notable investments include prominent biopharmaceutical players such as Clover Biopharmaceuticals and InventisBio. By bridging the gap between scientific research and commercialization, Zhangjiang Leading Capital plays a critical role in maintaining Shanghai's status as a global hub for biomedical innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhangjiang Leading Capital.